| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1031055926 |
| P356 | DOI | 10.1016/J.JASMS.2006.02.023 |
| P698 | PubMed publication ID | 16631376 |
| P5875 | ResearchGate publication ID | 7150101 |
| P2093 | author name string | Pavel V Bondarenko | |
| Thomas M Dillon | |||
| Himanshu S Gadgil | |||
| Gary D Pipes | |||
| Michael J Treuheit | |||
| P2860 | cites work | Signal peptide prediction based on analysis of experimentally verified cleavage sites | Q24645296 |
| Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity | Q27640312 | ||
| Therapeutic antibodies for human diseases at the dawn of the twenty-first century | Q34168125 | ||
| Pyroglutamic acid. Non-metabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal | Q38584564 | ||
| Processing of C-terminal lysine and arginine residues of proteins isolated from mammalian cell culture. | Q40450635 | ||
| Stability and CTL activity of N-terminal glutamic acid containing peptides | Q40794811 | ||
| Electrospray ionization mass spectrometry: Deconvolution by an Entropy-Based algorithm | Q45295921 | ||
| Reversed-phase liquid chromatography/mass spectrometry analysis of reduced monoclonal antibodies in pharmaceutics | Q46811900 | ||
| Effect of glycosylation on antibody function: implications for genetic engineering | Q46879419 | ||
| Optimization of a reversed-phase high-performance liquid chromatography/mass spectrometry method for characterizing recombinant antibody heterogeneity and stability | Q46920795 | ||
| Cell-free synthesis of amino-terminal L-pyroglutamic acid | Q47889412 | ||
| Analysis of glutamine, glutamic acid and pyroglutamic acid in protein hydrolysates by high-performance liquid chromatography | Q69860676 | ||
| Amino terminal sequences of human immunoglobulin heavy chains | Q70642099 | ||
| Validation of a peptide mapping method for a therapeutic monoclonal antibody: what could we possibly learn about a method we have run 100 times? | Q73524714 | ||
| P433 | issue | 6 | |
| P921 | main subject | antibody | Q79460 |
| high-performance liquid chromatography | Q381233 | ||
| electrospray ionization | Q902061 | ||
| P304 | page(s) | 867-872 | |
| P577 | publication date | 2006-04-21 | |
| P1433 | published in | Journal of the American Society for Mass Spectrometry | Q3020250 |
| P1476 | title | Improving mass accuracy of high performance liquid chromatography/electrospray ionization time-of-flight mass spectrometry of intact antibodies | |
| P478 | volume | 17 |
| Q46541519 | Accumulation of succinimide in a recombinant monoclonal antibody in mildly acidic buffers under elevated temperatures |
| Q53595800 | Cancer vaccine characterization: from bench to clinic. |
| Q50860928 | Combination of SDS-PAGE and intact mass analysis for rapid determination of heterogeneities in monoclonal antibody therapeutics. |
| Q81792390 | Comparison of LC and LC/MS methods for quantifying N-glycosylation in recombinant IgGs |
| Q94503762 | Computational Studies on the Mechanisms of Nonenzymatic Intramolecular Cyclization of the Glutamine Residues Located at N-Termini Catalyzed by Inorganic Phosphate Species |
| Q55872037 | Definitions of terms relating to mass spectrometry (IUPAC Recommendations 2013) |
| Q49090078 | Detecting monoclonal immunoglobulins in human serum using mass spectrometry |
| Q64247340 | Dilute-and-shoot analysis of therapeutic monoclonal antibody variants in fermentation broth: a method capability study |
| Q43278365 | Electrospray ionization quadrupole ion-mobility time-of-flight mass spectrometry as a tool to distinguish the lot-to-lot heterogeneity in N-glycosylation profile of the therapeutic monoclonal antibody trastuzumab. |
| Q44031303 | MS in the analysis of biosimilars |
| Q46905334 | Mass measurement and top-down HPLC/MS analysis of intact monoclonal antibodies on a hybrid linear quadrupole ion trap-Orbitrap mass spectrometer |
| Q51791478 | Molecular mass analysis of antibodies by on-line SEC-MS. |
| Q34080417 | Physicochemical and biological characterization of 1E10 anti-idiotype vaccine. |
| Q54768263 | Quantification of an intact monoclonal antibody, rituximab, by (RP)HPLC/DAD in compliance with ICH guidelines. |
| Q38062785 | The impact of mass spectrometry on the study of intact antibodies: from post-translational modifications to structural analysis. |
| Q39080325 | Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry |
Search more.